Jacques Galipeau, MD

Position title: Associate Dean for Therapeutics Development and Don and Marilyn Anderson Professor of Oncology

Email: jgalipeau@wisc.edu

Phone: (608) 262-6701

WI Institute Medical Research
1111 Highland Ave
Madison, WI 53705-2275

Organ System/Disease Focus:
Crohn's disease, GVHD, Multiple Sclerosis and neurodegenerative disease, cancer immunotherapy, tissue injury
Aligned Research Focus:
Mesenchymal stromal cells basic science and translational use, cell culture, B-regulatory cells, NK cells, activated lymphoid cells
Jacques Galipeau headshot


News Releases:
Research Description:

Jacques Galipeau, M.D. FRCP(C) is the Don and Marilyn Anderson Professor of Oncology within the Department of Medicine and UW Carbone Comprehensive Cancer Center at the University of Wisconsin in Madison, and is Associate Dean for Therapeutics Development at the University of Wisconsin School of Medicine & Public Health.  He is the director of the University of Wisconsin Advanced Cell Therapy Program whose mission is to develop personalized cell therapies for immune and malignant disorders and to promote and deploy first-in-human clinical trials of UW cell therapy innovations to improve outcomes for children and adults. Dr. Galipeau leads a research program in the study and use of mesenchymal stromal cells as an immunotherapy of catastrophic illnesses including cancer and immune disease. He has also developed the field of fusion engineered cytokines known as fusokines, as a novel pharmaceutical means of treating immune disorders and cancer.  He is an internationally recognized expert in translational development of cellular pharmaceuticals and the sponsor of a series of FDA-sanctioned clinical trials examining the use of personalized cell therapies.

Dr. Galipeau is President of the ISCT (International Society for Cell Therapy) 2022-2024

Website: www.pact.wisc.edu